| Literature DB >> 35268642 |
Paulo Wender P Gomes1,2, Luiza Martins3, Emilli Gomes4, Abraão Muribeca2, Sônia Pamplona2, Andrea Komesu5, Carissa Bichara2, Mahendra Rai6, Consuelo Silva2,7, Milton Silva2.
Abstract
Diseases caused by viruses are a global threat, resulting in serious medical and social problems for humanity. They are the main contributors to many minor and major outbreaks, epidemics, and pandemics worldwide. Over the years, medicinal plants have been used as a complementary treatment in a range of diseases. In this sense, this review addresses promising antiviral plants from Marajó island, a part of the Amazon region, which is known to present a very wide biodiversity of medicinal plants. The present review has been limited to articles and abstracts available in Scopus, Web of Science, Science Direct, Scielo, PubMed, and Google Scholar, as well as the patent offices in Brazil (INPI), United States (USPTO), Europe (EPO) and World Intellectual Property Organization (WIPO). As a result, some plants from Marajó island were reported to have actions against HIV-1,2, HSV-1,2, SARS-CoV-2, HAV and HBV, Poliovirus, and influenza. Our major conclusion is that plants of the Marajó region show promising perspectives regarding pharmacological potential in combatting future viral diseases.Entities:
Keywords: Amazon region; medicinal plants; plants extract; viral diseases
Mesh:
Substances:
Year: 2022 PMID: 35268642 PMCID: PMC8911695 DOI: 10.3390/molecules27051542
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) The main animals (primary hosts) responsible for zoonotic viral transmission; (B) Basic general mechanism about viral infection in human cells; (C) Contamination of several people in society; (D) Global health risks (e.g., pandemic, hospital overcrowding, several cases of pneumonia, thousand deaths).
Figure 2Compounds that, until this review, have already been reported to have antiviral activity for each species. Therefore, all compounds are referenced in Table 2, except Plectranthus amboinicus, from which a rich fraction of an unknown flavonoid was reported.
The main plants cited to treat viral diseases in Marajó Island.
| Species | Occurrence * | Native Name in Marajó | Part of Plant | Use and Indication | |
|---|---|---|---|---|---|
| Continent | Region | ||||
| Southern America | Brazil | Vindicá | L, B | Infusion used to treat common viruses | |
| Europe, Southern America | Northern europe, Brazil | Urucum | L | Infusion used to treat flu | |
|
| Southern America | Brazil | Limãozinho | JF | Juice used to treat flu |
| Southern America | Brazil | Limoeiro | BF | Infusion used to eliminate secretion from the lungs | |
| Europe, Southern America | Northern europe, Brazil | Mastruz | L | Juice is used to eliminate secretion from the lungs in viral infections | |
| Southern America | Brazil | Jucá | S | Infusion used to treat flu | |
| Southern America | Brazil | Alfavacão | L | Tea used to treat flu and cough | |
| South Africa, Southern America | Kenya, Angola, Mozambique, Swaziland, northern Natal, Brazil | Hortelã-Grande | L | Tea used to treat inflammation and sore throat | |
| Southern America | Brazil | Taperebazeiro | L, B | Infusion used against herpes virus | |
Note: L: Leaves; B: Bark; BF: Bark of Fruit; S: Seeds; JF: Juice of Fruit; O: Oil; * http://www.worldfloraonline.org/ (accessed on 15 January 2022).
Chemical components are probably involved in antiviral activities for main medicinal plants from Marajó Island.
| Medicinal Plant | Classes Chemical | Assignment Viral | Antiviral Agents | Methods | Action Mechanism | IC50 (µg/mL) | References |
|---|---|---|---|---|---|---|---|
| Aromatic heterocycles | HIV-1 | 5,6-Dehidrokavaina (DK) | Multiple integration assay | Inhibition HIV-1 integrase and Neuraminidase Activity | 4.4 μg/mL | [ | |
| Dihydro-5,6-dehydrokawain (DDK) | 3.6 μg/mL | ||||||
| Polyphenols | Influenza virus and | procyanidin B2 | CPE inhibition assay | Blockage of viral binding to the cell receptors | 50.85–56.02 μg/mL | [ | |
| lutein | ELISA assay | Inhibition of HBV transcription | 40 μg/mL | ||||
|
| Terpenes | Hepatitis A virus (HAV) | Limonene, β-pinene, andγ-terpinene | Reed and Muench method | Reducing HAV infectivity | 2.84 log TCID50/mL | [ |
| Flavonoids | Hepatitis A Virus (HAV) | procyanidin B2 | Reed and Muench method | The slight reduction in virus infectivity | 2.84 log TCID50/mL | [ | |
| Flavonoids | SARS-CoV-2 | rutin and nicotiflorin | 3CLpro and RdRp | Molecular docking with 3CLpro (main protease (Mpro)) |
| [ | |
| Polysaccharide | HSV-1 | Sulfated polysaccharide | Plaque reduction assay | Antiviral activity by its ability to prevent viral replication | 405 μg/mL | [ | |
| Poliovirus (PV) | 1.25-10 μg/mL | ||||||
| Terpenes and Alkaloid | HSV-1,2 | Eugenol | Plaque-based assays (PFU) method | Inhibition of virus replication | 16.2, and 250 µg/mL | [ | |
| HIV-1,2 | Thymol, and ursolic acidPheophytin-a | Direct destruction of the virion | 7 µM | ||||
| Flavonoids | HSV-1 | Flavonoids | cleavage of peptide substrate | HIV-1 protease inhibitor | 100 µg/mL | [ | |
| Flavonoids and | HSV-1 | tannin-rich | Vero E6 cells | Glycoproteins gB and gD of HSV-1 surface | 17.35 µg/mL | [ | |
| geraniin | 20.40 µg/mL |
Figure 3Future prospects for the use of medicinal plants from Marajó island for the discovery of antiviral candidates and the development of therapeutic alternatives.